Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of bupropion as a treatment for depression.

The National Institute for Health and Care Excellence (NICE) is the national body that provides authoritative, evidence-based guidance for healthcare professionals on the treatment of specific conditions. Bupropion does not have a United Kingdom marketing authorisation for use in the treatment of depression. NICE considered evidence on the off-label use of bupropion in the development of its guideline on the treatment and management of depression but did not make any recommendations on its use.